Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SRPT

Sarepta

$33.51

0.2 (0.60%)

14:25
06/21/17
06/21
14:25
06/21/17
14:25
Options
Sarepta call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$33.51

0.2 (0.60%)

07:05
06/21/17
06/21
07:05
06/21/17
07:05
Hot Stocks
Sarepta, Genethon announce gene therapy research collaboration »

Sarepta Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
SRPT

Sarepta

$32.83

0.88 (2.75%)

13:05
06/14/17
06/14
13:05
06/14/17
13:05
Options
Sarepta call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$31.95

0.48 (1.53%)

13:50
06/13/17
06/13
13:50
06/13/17
13:50
Hot Stocks
Sarepta CEO says Exondys 51 launch going 'very much how we had hoped' »

Sarepta CEO Ed Kaye said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

SRPT

Sarepta

$31.55

0.15 (0.48%)

10:59
06/09/17
06/09
10:59
06/09/17
10:59
Technical Analysis
Technical View: Sarepta near session highs, levels to watch »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

SRPT

Sarepta

$31.55

0.15 (0.48%)

10:51
06/09/17
06/09
10:51
06/09/17
10:51
Rumors
Rumor moving shares of Sarepta »

Rumor: Sarepta strength…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

SRPT

Sarepta

$31.40

-0.1 (-0.32%)

, ALIOF

Actelion

11:09
06/08/17
06/08
11:09
06/08/17
11:09
Hot Stocks
Sarepta seen as 'bargain' for potential big pharma buyer »

While approval for…

SRPT

Sarepta

$31.40

-0.1 (-0.32%)

ALIOF

Actelion

PFE

Pfizer

$31.96

-0.04 (-0.13%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$25.84

-0.18 (-0.69%)

JNJ

Johnson & Johnson

$130.87

0.12 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 09

    Jun

  • 09

    Jun

  • 13

    Jun

  • 15

    Jun

  • 02

    Aug

  • 27

    Aug

SRPT

Sarepta

$31.40

-0.1 (-0.32%)

06:01
06/08/17
06/08
06:01
06/08/17
06:01
Recommendations
Sarepta analyst commentary at Oppenheimer »

Sarepta would be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

PTCT

PTC Therapeutics

$14.31

0.76 (5.61%)

, SRPT

Sarepta

$31.50

0.06 (0.19%)

06:41
06/07/17
06/07
06:41
06/07/17
06:41
Recommendations
PTC Therapeutics, Sarepta analyst commentary at Citi »

PTC Therapeutics shares…

PTCT

PTC Therapeutics

$14.31

0.76 (5.61%)

SRPT

Sarepta

$31.50

0.06 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jun

  • 13

    Jun

  • 28

    Sep

  • 24

    Oct

Over a month ago
SRPT

Sarepta

$35.84

1.41 (4.10%)

07:28
05/19/17
05/19
07:28
05/19/17
07:28
Periodicals
Sarepta worked with parents to get FDA approval for eteplirsen, WSJ says »

After trial data for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.